{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:24:12Z","timestamp":1794576252806,"version":"4.9.1"},"reference-count":106,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2022,2,14]]},"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>The BTS clinical statement for the diagnosis and management of ocular tuberculosis (TB) draws on the expertise of both TB and and ophthalmic specialists to outline the current understanding of disease pathogenesis, diagnosis and management in adults. Published literature lacks high-quality evidence to inform clinical practice and there is also a paucity of data from animal models to elucidate mechanisms of disease. However, in order to improve and standardise patient care, this statement provides consensus points with the currently available data and agreed best practice.<\/jats:p>","DOI":"10.1136\/bmjresp-2022-001225","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T20:30:26Z","timestamp":1649104226000},"page":"e001225","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":38,"title":["BTS clinical statement for the diagnosis and management of ocular tuberculosis"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2647-4688","authenticated-orcid":false,"given":"Onn Min","family":"Kon","sequence":"first","affiliation":[{"name":"Chest and Allergy Clinic, Imperial College Healthcare NHS Trust, London, UK"},{"name":"National Heart and Lung Institute, Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8086-990X","authenticated-orcid":false,"given":"Nicholas","family":"Beare","sequence":"additional","affiliation":[{"name":"St Paul's Eye Unit, Liverpool University Hospitals, Liverpool, UK"},{"name":"Department of Eye and Vision Research, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Connell","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Damato","sequence":"additional","affiliation":[{"name":"Ophthalmology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gorsuch","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Manchester Royal Infirmary, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Hagan","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, City Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity","family":"Perrin","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Petrushkin","sequence":"additional","affiliation":[{"name":"Ophthalmology, Moorfields Eye Hospital City Road Campus, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Potter","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, North Middlesex University Hospital NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charanjit","family":"Sethi","sequence":"additional","affiliation":[{"name":"Ophthalmology, Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Stanford","sequence":"additional","affiliation":[{"name":"Ophthalmology, Guy's and St Thomas' Hospitals NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"key":"2025083112323782000_9.1.e001225.1","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025083112323782000_9.1.e001225.2","first-page":"1","article-title":"Tubercular Uveitis: Nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1","author":"Testi","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.3","first-page":"1","article-title":"Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop","author":"Agrawal","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.oret.2017.07.007","article-title":"Auramine-Rhodamine Stain-Detection of mycobacteria in ocular fluid","volume":"1","author":"Bajgai","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"2025083112323782000_9.1.e001225.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.11.021"},{"key":"2025083112323782000_9.1.e001225.6","first-page":"822","article-title":"Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales' disease","volume":"41","author":"Madhavan","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025083112323782000_9.1.e001225.7","doi-asserted-by":"publisher","DOI":"10.1007\/BF00163549"},{"key":"2025083112323782000_9.1.e001225.8","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2014.986584"},{"key":"2025083112323782000_9.1.e001225.9","first-page":"237","article-title":"Ocular Tuberculosis--A Clinical Conundrum","volume":"24","author":"Lee","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.10","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1167\/iovs.18-24102","article-title":"Global variations and challenges with tubercular uveitis in the Collaborative ocular tuberculosis study","volume":"59","author":"Agrawal","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025083112323782000_9.1.e001225.11","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/IAE.0000000000002194","article-title":"THE COLLABORATIVE OCULAR TUBERCULOSIS STUDY (COTS)-1: A Multinational Review of 251 Patients With Tubercular Retinal Vasculitis","volume":"39","author":"Gunasekeran","year":"2019","journal-title":"Retina"},{"key":"2025083112323782000_9.1.e001225.12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41433-019-0543-7","article-title":"Developing a pathway for the diagnosis and management of ocular tuberculosis. The pan-LOndon ocular tuberculosis Pathway-LOOP","volume":"34","author":"Petrushkin","year":"2020","journal-title":"Eye"},{"key":"2025083112323782000_9.1.e001225.13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jamaophthalmol.2017.4485","article-title":"Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1","volume":"135","author":"Agrawal","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"2025083112323782000_9.1.e001225.14","first-page":"1","article-title":"The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Description of the Spectrum of Choroidal Involvement in 245 Patients with Tubercular Uveitis","author":"Agrawal","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/09273948.2017.1406529","article-title":"The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends","volume":"27","author":"Agarwal","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.16","doi-asserted-by":"crossref","unstructured":"Kumar A . Ocular tuberculosis. Springer, 2017.","DOI":"10.1007\/978-3-319-57520-9"},{"key":"2025083112323782000_9.1.e001225.17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41433-018-0224-y","article-title":"Infectious uveitis: an Asian perspective","volume":"33","author":"Agarwal","year":"2019","journal-title":"Eye"},{"key":"2025083112323782000_9.1.e001225.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.102018","article-title":"Insights into the molecular pathogenesis of ocular tuberculosis","volume":"126","author":"Agrawal","year":"2021","journal-title":"Tuberculosis"},{"key":"2025083112323782000_9.1.e001225.19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1755-3768.2011.02200.x","article-title":"Use of Staurenghi lens angiography in the management of posterior uveitis","volume":"91","author":"Reeves","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"2025083112323782000_9.1.e001225.20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/IAE.0000000000001128","article-title":"Longitudinal follow-up of choroidal granulomas using enhanced depth imaging optical coherence tomography","volume":"37","author":"Invernizzi","year":"2017","journal-title":"Retina"},{"key":"2025083112323782000_9.1.e001225.21","doi-asserted-by":"publisher","DOI":"10.1080\/09273940600966400"},{"key":"2025083112323782000_9.1.e001225.22","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309531"},{"key":"2025083112323782000_9.1.e001225.23","doi-asserted-by":"crossref","DOI":"10.1186\/1869-5760-4-10","article-title":"Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis","volume":"4","author":"Balne","year":"2014","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2025083112323782000_9.1.e001225.24","doi-asserted-by":"publisher","DOI":"10.1054\/tuld.1999.0210"},{"key":"2025083112323782000_9.1.e001225.25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tube.2018.03.005","article-title":"Normalised quantitative polymerase chain reaction for diagnosis of tuberculosis-associated uveitis","volume":"110","author":"Barik","year":"2018","journal-title":"Tuberculosis"},{"key":"2025083112323782000_9.1.e001225.26","doi-asserted-by":"crossref","first-page":"904","DOI":"10.4103\/0301-4738.198857","article-title":"Polymerase chain reaction for Mycobacterium tuberculosis DNA detection from ocular fluids in patients with various types of choroiditis in a referral eye center in India","volume":"64","author":"Biswas","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"2025083112323782000_9.1.e001225.27","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2012.658134"},{"key":"2025083112323782000_9.1.e001225.28","first-page":"43","article-title":"Association of Mycobacterium tuberculosis in the causation of Eales' disease: an institutional experience","volume":"33 Suppl","author":"Singh","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"2025083112323782000_9.1.e001225.29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/09273948.2017.1287925","article-title":"Polymerase chain reaction and its correlation with clinical features and treatment response in tubercular uveitis","volume":"26","author":"Sudheer","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.08.011"},{"key":"2025083112323782000_9.1.e001225.31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/09273948.2018.1563705","article-title":"Current practices in ocular tuberculosis: a survey of Brazilian specialists","volume":"28","author":"Fern\u00e1ndez Zamora","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.32","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2014.926936"},{"key":"2025083112323782000_9.1.e001225.33","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2014.994784"},{"key":"2025083112323782000_9.1.e001225.34","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2010.483318"},{"key":"2025083112323782000_9.1.e001225.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12348-017-0141-4","article-title":"A retrospective cohort study of patients treated with anti-tuberculous therapy for presumed ocular tuberculosis","volume":"7","author":"Damato","year":"2017","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2025083112323782000_9.1.e001225.36","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2010.235"},{"key":"2025083112323782000_9.1.e001225.37","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.5588\/ijtld.18.0013","article-title":"Utility of routine chest radiography in ocular tuberculosis and sarcoidosis","volume":"22","author":"Shaw","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083112323782000_9.1.e001225.38","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2010.525680"},{"key":"2025083112323782000_9.1.e001225.39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/09273940903551821","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography in the evaluation of a patient with presumed ocular tuberculosis","volume":"18","author":"Mehta","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4103\/0301-4738.121091","article-title":"Clinical utility of 18 Fluorodeoxyglucose (FDG)-PET\/CT scans in patients with suspect ocular tuberculosis","volume":"61","author":"Mehta","year":"2013","journal-title":"Indian J Ophthalmol"},{"key":"2025083112323782000_9.1.e001225.41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/09273948.2016.1194436","article-title":"Observed patterns of systemic disease on PET\/CT scan in patients with presumed ocular tuberculosis: findings and hypotheses","volume":"26","author":"Mehta","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.42","unstructured":"Sethi CB M . Ocular tuberculosis in West London (2012-2017): clinical phenotypes and the role of FDG-PET imaging in identifying subclinical tuberculosis. Assoc Research Vision Ophthalmology., 2018."},{"key":"2025083112323782000_9.1.e001225.43","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2010.182659"},{"key":"2025083112323782000_9.1.e001225.44","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/09273948.2019.1685109","article-title":"The Role of \n                  18\n               F-FDG PET\/CT in Suspected Intraocular Sarcoidosis and Tuberculosis","volume":"29","author":"Burger","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.45","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/09273948.2018.1439068","article-title":"Role of Endobronchial Ultrasound Guided Transbronchial Needle Aspiration in the Diagnosis of Intraocular Inflammation in India - Our Experience","volume":"27","author":"Sudheer","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.46","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/09273948.2018.1425460","article-title":"Role of CT chest and cytology in differentiating tuberculosis from presumed sarcoidosis in uveitis","volume":"27","author":"Bansal","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.47","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/09273948.2017.1322615","article-title":"Role of endoscopic ultrasound in the management of tubercular uveitis","volume":"26","author":"Sharma","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.48","unstructured":"NICE . Nice guideline tuberculosis. London: NICE, 2019."},{"key":"2025083112323782000_9.1.e001225.49","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30355-4"},{"key":"2025083112323782000_9.1.e001225.50","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30276-0","article-title":"Interferon-\u03b3 release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis","volume":"20","author":"Zhou","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2025083112323782000_9.1.e001225.51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1473-3099(18)30613-3","article-title":"Clinical utility of existing and second-generation interferon-\u03b3 release assays for diagnostic evaluation of tuberculosis: an observational cohort study","volume":"19","author":"Whitworth","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2025083112323782000_9.1.e001225.52","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207811"},{"key":"2025083112323782000_9.1.e001225.53","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ajo.2018.03.032","article-title":"Effect of antituberculous therapy on uveitis associated with latent tuberculosis","volume":"190","author":"Tomkins-Netzer","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"2025083112323782000_9.1.e001225.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2014.01.031"},{"key":"2025083112323782000_9.1.e001225.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.02.006"},{"key":"2025083112323782000_9.1.e001225.56","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-017-0597-x","article-title":"What does IGRA testing add to the diagnosis of ocular tuberculosis? A Bayesian latent class analysis","volume":"17","author":"Agrawal","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"2025083112323782000_9.1.e001225.57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2019.11.009","article-title":"Prevalence of positive QuantiFERON-TB gold In-Tube test in uveitis and its clinical implications in a country nonendemic for tuberculosis","volume":"211","author":"Groen-Hakan","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"2025083112323782000_9.1.e001225.58","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.survophthal.2016.03.001","article-title":"Anti-Tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis","volume":"61","author":"Kee","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"2025083112323782000_9.1.e001225.59","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3109\/09273948.2015.1019155","article-title":"Moxifloxacin: an alternative to ethambutol for the treatment of presumed ocular tuberculosis","volume":"24","author":"Potter","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.60","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-300209"},{"key":"2025083112323782000_9.1.e001225.61","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4274\/tjo.galenos.2019.05874","article-title":"Clinical profile and treatment response of patients with ocular inflammation due to presumed ocular tuberculosis: a retrospective study","volume":"49","author":"Elangovan","year":"2019","journal-title":"Turk J Ophthalmol"},{"key":"2025083112323782000_9.1.e001225.62","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-019-0543-7","article-title":"Developing a pathway for the diagnosis and management of ocular tuberculosis. The pan-LOndon ocular tuberculosis Pathway-LOOP","volume":"34","author":"Petrushkin","year":"2020","journal-title":"Eye"},{"key":"2025083112323782000_9.1.e001225.63","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/09273948.2017.1400074","article-title":"The role of dexamethasone implant in the management of tubercular uveitis","volume":"26","author":"Agarwal","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.64","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1089\/jop.2016.0097","article-title":"Interferon alpha for the treatment of cystoid macular edema associated with presumed ocular tuberculosis","volume":"33","author":"Oray","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"key":"2025083112323782000_9.1.e001225.65","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/09273948.2018.1431292","article-title":"Interferon alpha-2a for the treatment of post-infectious uveitis secondary to presumed intraocular tuberculosis","volume":"27","author":"Invernizzi","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.66","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-019-4432-8","article-title":"Visual and treatment outcomes of tubercular uveitis: a prospective case series from a referral hospital in Pakistan","volume":"12","author":"Ghauri","year":"2019","journal-title":"BMC Res Notes"},{"key":"2025083112323782000_9.1.e001225.67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273948.2018.1541326","article-title":"Antituberculous treatment itself might prevent visual impairment in presumed Tuberculosis-Related uveitis","volume":"28","author":"Lloren\u00e7","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.68","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/09273948.2017.1383446","article-title":"Clinical outcomes of adjunctive sustained-release intravitreal dexamethasone implants in tuberculosis-associated multifocal Serpigenoid choroiditis","volume":"26","author":"Jain","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"2025083112323782000_9.1.e001225.70","doi-asserted-by":"publisher","DOI":"10.1080\/08820530802520095"},{"key":"2025083112323782000_9.1.e001225.71","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1055\/s-0043-124966","article-title":"Need for quantitative measurement methods for posterior uveitis: comparison of dual FA\/ICGA angiography, EDI-OCT choroidal thickness and sun vitreous haze evaluation in stromal choroiditis","volume":"235","author":"Fabro","year":"2018","journal-title":"Klin Monbl Augenheilkd"},{"key":"2025083112323782000_9.1.e001225.72","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.12659\/MSM.901744","article-title":"Observation and clinical pattern in patients with white dot syndromes: the role of color photography in monitoring ocular changes in long-term observation","volume":"23","author":"Brydak-Godowska","year":"2017","journal-title":"Med Sci Monit"},{"key":"2025083112323782000_9.1.e001225.73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40942-017-0069-8","article-title":"Multi-modal imaging and anatomic classification of the white dot syndromes","volume":"3","author":"Raven","year":"2017","journal-title":"Int J Retina Vitreous"},{"key":"2025083112323782000_9.1.e001225.74","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-020-01336-6","article-title":"Systemic corticosteroid use in UK uveitis practice: results from the ocular inflammation steroid toxicity risk (ostrich) study","volume":"35","author":"Leandro","year":"2021","journal-title":"Eye"},{"key":"2025083112323782000_9.1.e001225.75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273948.2020.1744669","article-title":"Lessons in digital epidemiology from COTS-1: coordinating multicentre research across 10 countries using operational and technology innovation to overcome funding deficiencies","author":"Gunasekeran","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.76","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw694"},{"key":"2025083112323782000_9.1.e001225.77","unstructured":"WHO . WHO guidelines on tuberculosis. WHO, 2018."},{"key":"2025083112323782000_9.1.e001225.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.09.048"},{"key":"2025083112323782000_9.1.e001225.79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1574886310666151014114925","article-title":"Biologic therapy in inflammatory eye conditions (Ophtalmology): safety profile","volume":"11","author":"Neri","year":"2016","journal-title":"Curr Drug Saf"},{"key":"2025083112323782000_9.1.e001225.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.05.006"},{"key":"2025083112323782000_9.1.e001225.81","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110"},{"key":"2025083112323782000_9.1.e001225.82","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.118935"},{"key":"2025083112323782000_9.1.e001225.83","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu185"},{"key":"2025083112323782000_9.1.e001225.84","doi-asserted-by":"publisher","DOI":"10.1002\/art.21043"},{"key":"2025083112323782000_9.1.e001225.85","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.01.003"},{"key":"2025083112323782000_9.1.e001225.86","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140101"},{"key":"2025083112323782000_9.1.e001225.87","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1093\/rheumatology\/key208","article-title":"The British Society for rheumatology biologic DMARD safety guidelines in inflammatory arthritis","volume":"58","author":"Holroyd","year":"2019","journal-title":"Rheumatology"},{"key":"2025083112323782000_9.1.e001225.88","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/0970-2113.148428","article-title":"A prospective study of ocular toxicity in patients receiving ethambutol as a part of directly observed treatment strategy therapy","volume":"32","author":"Garg","year":"2015","journal-title":"Lung India"},{"key":"2025083112323782000_9.1.e001225.89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1966.tb45532.x"},{"key":"2025083112323782000_9.1.e001225.90","doi-asserted-by":"crossref","DOI":"10.1136\/bjophthalmol-2012-301870","article-title":"Ethambutol-Induced optic neuropathy: a nationwide population-based study from Taiwan","volume":"96","author":"Chen","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"2025083112323782000_9.1.e001225.91","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0766"},{"key":"2025083112323782000_9.1.e001225.92","first-page":"56","article-title":"Ocular toxicity of ethambutol","volume":"12","author":"Chan","year":"2006","journal-title":"Hong Kong Med J"},{"key":"2025083112323782000_9.1.e001225.93","first-page":"1","article-title":"Ocular toxicity with ethambutol therapy: timely recaution","volume":"32","author":"Koul","year":"2015","journal-title":"Lung India"},{"key":"2025083112323782000_9.1.e001225.94","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/ICU.0000000000000416","article-title":"Ethambutol optic neuropathy","volume":"28","author":"Chamberlain","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"2025083112323782000_9.1.e001225.95","unstructured":"RCOphth . RCOphth statement on ethambutol toxicity: RCOphth, 2017. Available: https:\/\/www.rcophth.ac.uk\/2017\/10\/rcophth-statement-on-ethambutol-toxicity\/"},{"key":"2025083112323782000_9.1.e001225.96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.06.011"},{"key":"2025083112323782000_9.1.e001225.97","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200510-1666ST"},{"key":"2025083112323782000_9.1.e001225.98","doi-asserted-by":"crossref","unstructured":"Meira L , Boaventura R , Ara\u00fajo D . Clinical presentation and mortality of tuberculosis in the elderly. Eur Respir J 2016;48.doi:10.1183\/13993003.congress-2016.PA2653","DOI":"10.1183\/13993003.congress-2016.PA2653"},{"key":"2025083112323782000_9.1.e001225.99","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-13-121","article-title":"Clinical characteristics and treatment outcomes of tuberculosis in the elderly: a case control study","volume":"13","author":"Kwon","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2025083112323782000_9.1.e001225.100","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/eye.2013.5","article-title":"Progressive ocular inflammation following anti-tubercular therapy for presumed ocular tuberculosis in a high-endemic setting","volume":"27","author":"Basu","year":"2013","journal-title":"Eye"},{"key":"2025083112323782000_9.1.e001225.101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.eimc.2018.01.001","article-title":"Molecular epidemiology of tuberculosis","volume":"36","author":"Coll","year":"2018","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2025083112323782000_9.1.e001225.102","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw625"},{"key":"2025083112323782000_9.1.e001225.103","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2174\/1389201020666190430114121","article-title":"Tuberculosis: current status, diagnosis, treatment and development of novel vaccines","volume":"20","author":"Yadav","year":"2019","journal-title":"Curr Pharm Biotechnol"},{"key":"2025083112323782000_9.1.e001225.104","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.082."},{"key":"2025083112323782000_9.1.e001225.105","first-page":"1","article-title":"Ocular Tuberculosis: More than 'Of Mice and Men'","author":"Mitchell","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"2025083112323782000_9.1.e001225.106","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00021-18","article-title":"Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection","volume":"31","author":"Drain","year":"2018","journal-title":"Clin Microbiol Rev"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2022-001225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T19:32:51Z","timestamp":1756668771000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2022-001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,4,4]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/bmjresp-2022-001225"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2022-001225","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}